Our R&D program encompasses collaborations with leading scientists at Uppsala University, Karolinska Institutet and Linköping University. DoloRadix AB, thereby, combines its deep clinical knowhow with expertise in fields such as nanophysics, material sciences, neurophysiology, mass spectromoty, proteomics and medical informatics.